相似文献
1
EPCR shedding light on sickle nephropathy.内皮蛋白C受体揭示镰状肾病。
Blood. 2024 Aug 1;144(5):472-474. doi: 10.1182/blood.2024025479.
2
AJKD Atlas of Renal Pathology: Sickle Cell Nephropathy.《美国肾脏病学会杂志》肾脏病理学图谱：镰状细胞肾病
Am J Kidney Dis. 2016 Jul;68(1):e1-3. doi: 10.1053/j.ajkd.2016.05.003.
3
Sickle cell nephropathy.镰状细胞肾病
Adv Nephrol Necker Hosp. 1994;23:133-47.
4
Glomerular lesions in sickle cell nephropathy.镰状细胞肾病中的肾小球病变
JAMA. 1971 Jan 18;215(3):437-40.
5
Renal hemosiderosis complicating sickle cell anemia.镰状细胞贫血并发肾含铁血黄素沉着症。
Kidney Int. 2012 Apr;81(7):709. doi: 10.1038/ki.2011.470.
6
[Renal amyloidosis: uncommon complication of sickle cell disease].[肾淀粉样变性：镰状细胞病的罕见并发症]
Med Trop (Mars). 2011 Apr;71(2):185-6.
7
Renal protection by atorvastatin in a murine model of sickle cell nephropathy.阿托伐他汀在镰状细胞肾病小鼠模型中的肾脏保护作用。
Br J Haematol. 2018 Apr;181(1):111-121. doi: 10.1111/bjh.15157. Epub 2018 Mar 12.
8
Editorial: The sickle cell kidney.社论：镰状细胞肾病
J Assoc Physicians India. 1975 Mar;23(3):209-11.
9
Medullary peritubular capillary thrombi: a harbinger of sickle cell nephropathy.髓质肾小管周围毛细血管血栓形成：镰状细胞肾病的先兆。
Kidney Int. 2014 Oct;86(4):861. doi: 10.1038/ki.2014.94.
10
Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients.镰状细胞病肾病：儿科患者风险因素和潜在生物标志物的最新研究进展。
Biomark Med. 2019 Aug;13(11):967-987. doi: 10.2217/bmm-2019-0105. Epub 2019 Aug 8.
本文引用的文献
1
Heme-induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice.血红素诱导的肾血管内皮蛋白 C 受体缺失促进镰状细胞小鼠的慢性肾脏病。
Blood. 2024 Aug 1;144(5):552-564. doi: 10.1182/blood.2023023528.
2
Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease.蛋白酶激活受体-1 的偏性激动调节小鼠镰状细胞病中的血栓炎症。
Blood Adv. 2024 Jun 25;8(12):3272-3283. doi: 10.1182/bloodadvances.2023011907.
3
Natural history and variability in albuminuria in pediatric and murine sickle cell anemia.儿童和鼠类镰状细胞贫血中白蛋白尿的自然史和变异性。
Blood Adv. 2023 Nov 28;7(22):6850-6858. doi: 10.1182/bloodadvances.2023010101.
4
Emerging Therapies and Advances in Sickle Cell Disease with a Focus on Renal Manifestations.新兴疗法与镰状细胞病研究进展：聚焦肾脏表现
Kidney360. 2023 Jul 1;4(7):997-1005. doi: 10.34067/KID.0000000000000162. Epub 2023 May 31.
5
Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System study.患有镰状细胞病并发展为终末期肾病的患者生存率仍然很低——一项对美国肾脏数据系统长达19年的研究。
Br J Haematol. 2022 Dec;199(5):e43-e47. doi: 10.1111/bjh.18494. Epub 2022 Oct 3.
6
Activated Protein C Strengthens Cardiac Tolerance to Ischemic Insults in Aging.活化蛋白 C 增强衰老心脏对缺血性损伤的耐受性。
Circ Res. 2022 Jan 21;130(2):252-272. doi: 10.1161/CIRCRESAHA.121.319044. Epub 2021 Dec 21.
7
Hemopexin deficiency promotes acute kidney injury in sickle cell disease.贫血抑制素缺乏促进镰状细胞病急性肾损伤。
Blood. 2020 Mar 26;135(13):1044-1048. doi: 10.1182/blood.2019002653.
8
Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.在儿科镰状细胞肾病中，儿童早期的超滤作用先于蛋白尿。
Am J Hematol. 2019 Apr;94(4):417-423. doi: 10.1002/ajh.25390. Epub 2019 Jan 8.
9
Renal endothelial protein C receptor expression and shedding during diabetic nephropathy.糖尿病肾病过程中肾脏内皮蛋白 C 受体的表达和脱落。
J Thromb Haemost. 2016 Jun;14(6):1171-82. doi: 10.1111/jth.13315. Epub 2016 May 6.
10
Activated protein C: biased for translation.活化蛋白C：偏向翻译。
Blood. 2015 May 7;125(19):2898-907. doi: 10.1182/blood-2015-02-355974. Epub 2015 Mar 30.
Zotero 插件